Dr. John Taylor, MD is a radiation oncology specialist in Oklahoma City, OK and has been practicing for 32 years. He specializes in radiation oncology.


Insurance Check

Search for your insurance provider

Dr. Taylor accepts

Accepted insurance can change. Please double-check when making an appointment.

(405) 529-6673

Dr. Taylor accepts the following insurance:

Aetna
Aetna HMO
Choice Plus POS II
Assurant Health
Blue Cross Blue Shield
Blue Card PPO
CHAMPVA
Cigna
Great West Healthcare-Cigna PPO
Open Access
Commercial Insurance Company
CoreSource
Coventry Health Care
Coventry Health Care of Oklahoma
Coventry Health Care of Oklahoma HMO
First Health (Coventry Health Care)
First Health (Coventry Health Care) PPO
Golden Rule
Government Employees Health Association (GEHA)
GEHA
Humana
Choice Care PPO
Mail Handlers Benefit Plan (MHBP)
Medicaid
MultiPlan
MultiPlan PPO
PHCS Network PPO
Principal Financial Group
Tricare
TriCare for Life
UnitedHealthCare
Options PPO
PacifiCare
United Healthcare
Universal American

Background Check

Healthgrades does not collect malpractice claims information for Oklahoma
No disciplinary actions found for the years we collect data
No board actions found for the years we collect data
Learn more about background checks

Experience Check

Check Dr. Taylor's experience treating your condition or procedure

Dr. Taylor's Top Procedures and Conditions

Treatment Frequency
Cancer
very high
very high

Treatment Frequency

Dr. Taylor treats Cancer more than 97% of his peers

Dr. Taylor treats this condition more than 97% of his peers

Rating Includes other areas of care:

  • Adenoid Cystic Carcinoma
  • Adolescent Cancer
  • Adrenal Cortical Carcinoma
  • Adrenal Gland Cancer
  • Adult Cerebral Astrocytoma
  • Adult Small Cell Lung Cancer
  • Ampullary Carcinoma
  • Anal and Rectal Cancer
  • Anal Cancer
  • Anaplastic Oligodendroglioma
  • Angiosarcoma of the Breast
  • Appendix Cancer
  • Astrocytoma
  • Basal Cell Carcinoma (BCC)
  • Basal Type Breast Cancer
  • Benign Astrocytoma
  • Bile Duct Cancer
  • Biliary Cancer
  • Bladder Cancer
  • Blood Cancer
  • Bone Cancer
  • Brain and Nervous System Cancer (Includes: Gliomas, Astrocytoma, Schwannoma, Medulloblastoma, Chordoma)
  • Brain Cancer
  • Brainstem Glioma
  • Breast Cancer
  • Breast Cancer Recurrence
  • Bronchioalveolar Carcinoma
  • Bronchogenic Carcinoma
  • Cancer of Floor of Mouth
  • Cerebellar Astrocytoma
  • Cerebral Astrocytoma
  • Cervical Cancer
  • Cholangiocarcinoma
  • Chordoma
  • Choriocarcinoma
  • Chromophobe Renal Cell Carcinoma
  • Clear Cell Adenocarcinoma
  • Clear Cell Renal Cell Carcinoma
  • Colorectal Cancer
  • Cutaneous Squamous Cell Carcinoma
  • Distal Colorectal Cancer
  • Distal Gastrointestinal Tract Cancers
  • Ductal Carcinoma in Situ
  • Duodenal Cancer
  • Ear Cancer
  • Endocrine Cancer
  • Endometrial Cancer
  • ENT Cancer
  • Epidermoid Carcinoma
  • Epithelial-Myoepithelial Carcinoma
  • Esophageal Cancer
  • Extrahepatic Bile Duct Cancer
  • Eye Cancer
  • Facial Skin Cancer
  • Fallopian Tube Cancer
  • Familial Colorectal Cancer
  • Familial Pancreatic Cancer
  • Familial Renal Cancer
  • Familial Renal Cell Carcinoma
  • Fibrolamellar Hepatocellular Carcinoma
  • Follicular Adenocarcinoma
  • Follicular Thyroid Cancer
  • Gall Bladder Cancer
  • Gallbladder & Biliary Tract Cancer
  • Gastric Cancer, Borrmann 4
  • Gastroenterologic Cancer (Colon, Stomach, Esophageal, Liver)
  • Genital System Cancer
  • Genitourinary Cancers
  • Gland Cancer
  • Glassy Cell Carcinoma
  • Glioma
  • Gliomatosis Cerebri
  • Gynecologic Cancer
  • Hamartomatous Colorectal Cancer
  • Heart Cancer
  • Hepatobiliary Cancer
  • Hepatocellular Cancer
  • Hepatocellular Carcinoma
  • Hip Cancer
  • Hypopharyngeal Cancer
  • Inflammatory Breast Cancer
  • Infundibulocystic Basal Cell Carcinoma
  • Intestinal Cancer
  • Intrahepatic Cholangiocarcinoma
  • Invasive Breast Cancer
  • Invasive Ductal Carcinoma
  • Invasive Lobular Carcinoma
  • Joint Cancer
  • Juvenile Pilocytic Astrocytoma
  • Laryngeal Cancer
  • Laryngeal Carcinoma
  • Limb Cancer
  • Lip Cancer
  • Liver Cancer
  • Locally Advanced Breast Cancer
  • Lung Cancer
  • Lymphoma of the Breast
  • Male Breast Cancer
  • Male Genitourinary Cancer
  • Malignant Astrocytoma
  • Malignant Breast Tumor
  • Malignant Glioma
  • Mediastinal Cancer
  • Medullary Thyroid Cancer
  • Medulloblastoma
  • Melanoma-Astrocytoma Syndrome
  • Merkel Cell Cancer
  • Metastatic Adrenal Gland Cancer
  • Metastatic Blood Cancer
  • Metastatic Bone Cancer
  • Metastatic Breast Cancer
  • Metastatic Cancer
  • Metastatic Liver Cancer
  • Metastatic Lymph Cancer
  • Metastatic Nervous System Cancer
  • Metastatic Prostate Cancer
  • Metastatic Skin Cancer
  • Metastatic Soft Tissue Cancer
  • Metastatic Spinal Cord Cancer
  • Metastatic Squamous Neck Cancer With Occult Primary
  • MSI-H Colorectal Cancer
  • MSI-L Colorectal Cancer
  • MSS Colorectal Cancer
  • Muscle Cancer
  • Nasal Cavity Cancer
  • Nasopharyngeal Cancer
  • Neck Cancer
  • Nerve Cancer
  • Neuroendocrine Cancer
  • Nevoid Basal Cell Carcinoma Syndrome
  • Nodular Basal Cell Carcinoma
  • Noduloulcerative Basal Cell Carcinoma
  • Non-Melanoma Skin Cancer
  • Nonpolyposis Colorectal Cancer, Familial
  • Non-Small Cell Lung Cancer
  • Nose Cancer
  • Oligodendroglioma
  • Oral Cancer
  • Oral Squamous Cell Carcinoma
  • Oropharyngeal Cancer
  • Oropharyngeal Cancer, Adult
  • Osteosarcoma of the Breast
  • Ovarian Cancer
  • Ovarian Epithelial Cancer
  • Palate Cancer
  • Pancreatic Cancer
  • Pancreatic Islet Cell Cancer
  • Papillary Renal Cell Carcinoma
  • Papillary Thyroid Cancer
  • Paranasal Sinus Cancer
  • Parathyroid (Gland) Cancer
  • Parathyroid Carcinoma
  • Parotid Gland Cancer
  • Pediatric Cancer
  • Pelvic Cancer
  • Penile Cancer
  • Pharyngeal Cancer
  • Pigmented Basal Cell Carcinoma
  • Pleura Cancer
  • Pre-Invasive Breast Cancer
  • Primary Prostate Cancer
  • Prostate Cancer
  • Prostate Cancer - Hereditary - 1
  • Prostate Cancer - Hereditary - 10
  • Prostate Cancer - Hereditary - 11
  • Prostate Cancer - Hereditary - 14
  • Prostate Cancer - Hereditary - 2
  • Prostate Cancer - Hereditary - 3
  • Prostate Cancer - Hereditary - 4
  • Prostate Cancer - Hereditary - 5
  • Prostate Cancer - Hereditary - 6
  • Prostate Cancer - Hereditary - 7
  • Prostate Cancer - Hereditary - 8
  • Prostate Cancer - Hereditary - 9
  • Prostate Cancer - Hereditary - X-Linked 1
  • Prostate Cancer - Hereditary - X-Linked 2
  • Prostate Cancer - Hereditary -12
  • Prostate Cancer - Hereditary -13
  • Prostate Cancer - Hereditary -15
  • Radiation-Induced Angiosarcoma of the Breast
  • Rectal Cancer
  • Renal (Kidney) Cancer
  • Renal Cell Cancer
  • Respiratory System Cancer
  • Retinal Cancer
  • Salivary Gland Cancer
  • Sebaceous Gland Carcinoma
  • Secretory Breast Carcinoma
  • Sinonasal Undifferentiated Carcinoma
  • Sinus Cancer
  • Skin Cancer
  • Small Cell Lung Cancer
  • Spinal Cord Cancer
  • Spleen Cancer
  • Sporadic Colorectal Cancer
  • Squamous Cell Carcinoma
  • Squamous Cell Carcinoma of Conjunctiva
  • Squamous Cell Carcinoma of Head and Neck
  • Stomach and Small Intestine Cancer
  • Stomach Cancer
  • Stomach Cancer, Familial
  • Superficial Basal Cell Carcinoma
  • Supraglottic Laryngeal Cancer
  • Testicular Cancer
  • Thoracic Cancer
  • Throat Cancer
  • Thymus Cancer
  • Thyroid Cancer
  • Thyroid Cancer, Anaplastic
  • Thyroid Cancer, Familial Medullary
  • Thyroid Cancer, Hurthle Cell
  • Tongue Cancer
  • Trachea Cancer
  • Transitional Cell Cancer
  • Transitional Cell Carcinoma
  • Tubular Carcinoma
  • Urachal Cancer
  • Ureteral Cancer
  • Urinary Tract Cancer
  • Uterine Cancer
  • Vaginal Cancer
  • Visual Pathway and Hypothalamic Glioma
  • Vocal Cord Carcinoma
  • Vulvar Cancer
Bladder Cancer
normal
normal

Treatment Frequency

Dr. Taylor treats Bladder Cancer more than 5% of his peers

Dr. Taylor treats this condition more than 5% of his peers

Rating Includes other areas of care:

  • Urachal Cancer
Colorectal Cancer
normal
normal

Treatment Frequency

Dr. Taylor treats Colorectal Cancer more than 5% of his peers

Dr. Taylor treats this condition more than 5% of his peers

Rating Includes other areas of care:

  • Distal Colorectal Cancer
  • Familial Colorectal Cancer
  • Hamartomatous Colorectal Cancer
  • MSI-H Colorectal Cancer
  • MSI-L Colorectal Cancer
  • MSS Colorectal Cancer
  • Nonpolyposis Colorectal Cancer, Familial
  • Rectal Cancer
  • Sporadic Colorectal Cancer

Dr. Taylor's conditions and procedures:

  • 3D Conformal Radiotherapy
  • Bladder Cancer
  • Brain Cancer
  • Brain Tumor
  • Breast Cancer
  • Breast Cancer Treatment
  • Cancer
  • Cancer Counseling
  • Cancer Treatment
  • Cervical Cancer
  • Colorectal Cancer
  • CyberKnife® Robotic Radiosurgery
  • Esophageal Cancer
  • External Beam Radiotherapy
  • Gynecologic Cancer
  • Image-Guided Radiation Therapy (IGRT)
  • Intensity-Modulated Radiation Therapy (IMRT)
  • Laryngeal Cancer
  • Lung Cancer
  • Lymphoma
  • Pancreatic Cancer
  • Pituitary Gland Cancer
  • Prostate Brachytherapy
  • Prostate Cancer
  • Prostate Radioactive Seed Implants
  • Radiation Therapy
  • Rectal Cancer
  • Sarcoma
  • Skin Cancer
  • Stereotactic Radiosurgery
  • Stereotactic Radiosurgery, Spinal or Cranial
  • Thyroid Cancer
  • Vulvar Cancer

About Me

Biography

Dr. John Taylor, MD is a radiation oncology specialist in Oklahoma City, OK and has been practicing for 32 years. He specializes in radiation oncology.

Specialties

  • Radiation Oncology

Board Certifications

Education

Austin Med Educ Program Seton Hlt
Residency Hospital
1991
University Of Ok College Of Med
Residency Hospital
1988
Central Texas Medial Foundation
Internship Hospital
1987
University of Oklahoma / Health Sciences Center
Medical School
1984
University of Oklahoma Health Sciences Center
Undergraduate School
1983
University of Oklahoma Health Sciences Center
1981
University of Oklahoma
Undergraduate School
1991
1988
1987
1984
1983
1981

Awards

Dr. Taylor's Reviews

Likelihood to recommend Dr. Taylor

4.5

Based on 8 reviews

5 Stars
87.5%
(7)
4 Stars
0%
(0)
3 Stars
0%
(0)
2 Stars
0%
(0)
1 Star
12.5%
(1)

Leave a review

How likely are you to recommend
Dr. Taylor?
(Select your rating)
Average Reported Wait Time
  • Under 10 minutes
Dr. Taylor's Performance
  • Trustworthiness
  • Explains condition(s) well
  • Answers questions
  • Time well spent
Office & Staff Performance
  • Scheduling
  • Office environment
  • Staff friendliness
What People Say About Dr. John Taylor, MD
RecentHighestLowestMost Helpful
Reply
Such a caring man, AND fantastic Dr.
Was this helpful?
thumbs up icon option
thumbs down icon option
×Post a ResponseAre you Dr. John Taylor, MD?
Reply
I was diagnosed with prostate cancer January of 2017. I was referred to procure. I would highly recommend Procure to anyone needing their services. From the front desk ladies to the RN asigned to me to Dr Taylor all the way to the radiation crew. All were dedicated to make an unpleasant treatment a fun experience.. Once again I highly recommend Procure.
Was this helpful?
thumbs up icon option
thumbs down icon option
×Post a ResponseAre you Dr. John Taylor, MD?
Reply
Dr Taylor preformed Brachytherapy on me and I can tell you my personal experience was Excellant. He is very caring and you just feel he is the most qualified Dr for this procedure and you just feel like you are in the best hands!! I couldn't have asked for or gotten better care from Dr Taylor and the follow-up visits are great. The Brachytherapy was the absolute best choice for me and my PSA is down under .02. I could not be happier. His Staff is excellant, caring and always call me by name.
Was this helpful?
thumbs up icon option5
thumbs down icon option
×Post a ResponseAre you Dr. John Taylor, MD?

Leave a review

How was your experience with Dr. Taylor?

Affiliated Hospitals

Check the quality of care at hospitals where Dr. Taylor treats patients.

Learn more

83% Patient experience rating, 14% higher than the national average

  • Outstanding Patient Experience Award™ (2019, 2018)

67% Patient experience rating, 2% lower than the national average

76% Patient experience rating, 7% higher than the national average

  • Patient Safety Excellence Award™ (2017)

76% Patient experience rating, 7% higher than the national average

  • Patient Safety Excellence Award™ (2018)

87% Patient experience rating, 18% higher than the national average

More Radiation Oncology Specialists at INTEGRIS